Expanded/Activated Gamma Delta T-cell Infusion
Phase I Study of Ex Vivo Expanded/Activated Gamma Delta T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 38 patients (estimated)
- Sponsors
- University of Kansas Cancer Center
- Collaborators
- In8bio Inc.
- Tags
- T Cell, Adoptive Cellular Therapy, Post-Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1593
- NCT Identifier
- NCT03533816
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.